Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Parallel Session 4415

Biomarkers in Parkinsonism: From Research to Clinic

Panel Discussion

Wednesday, October 8, 2025
14:00 - 15:30 | Room TBD

In this session, the faculty will present updated biomarkers based on the platforms of seeding assay and -omics in Parkinson's disease and atypical parkinsonism, focusing on their potential clinical applications.


Chairs:

Michele Hu, United Kingdom
Edwin Jabbari, United Kingdom

Presenters:

CSF Biomarkers
Alicia Garrido Pla, Spain

Tissue Biomarkers
Chaewon Shin, South Korea

Blood-Based Biomarkers
Louis Tan, Singapore

CSPC Liaisons:

Chin-Hsien Lin, Taiwan
Huw Morris, United Kingdom

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Discuss CSF biomarkers for the early diagnosis and monitoring of disease progression in Parkinson's disease and atypical parkinsonism
  2. Describe the role of tissue biomarkers in Parkinson’s disease, focusing on their biological significance and translational applications in clinical practice
  3. Report advancements in blood-based biomarkers including -omics in parkinsonism and their role in enhancing diagnostic accuracy and monitoring disease progression

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Intermediate / Experienced

Focus

Basic Science
Translational